Carbidopa-chem-str (Carbidopa Chem Str)
Carbidopa, Levodopa And Entacapone
Product Images NDC 47335-004
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Carbidopa, Levodopa And Entacapone (NDC 47335-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Entacapone-chem-str (Entacapone Chem Str)
Levodopa-chem-str (Levodopa Chem Str)
Spl-carton1 (Spl Carton1)
This is a description of a medication that contains Carbidopa, Levodopa, and Entacapone. The recommended dosage information can be found on the package insert. It is advised to swallow the tablet whole without crushing, splitting or chewing it. The medication should be stored at a temperature of 25°C (77°F), and the excursions are permitted between 15-30°C (59-86°F). Keep it in a tight container and away from children. The medication is manufactured by Orion Corporation in Finland and is distributed by Sun Pharmaceutical Industries Inc. The batch number is provided.*
Spl-carton2 (Spl Carton2)
This text is medication information for Garhidopa, Levodopa, and Entacapone Tablets. The package insert provides instructions for use, dosage, storage, and dispensation of the medication. The medication should be swallowed whole and stored between 15-30°C (59-86°F). The tablets should be kept in a tight container and out of reach of children. The tablets contain Cabidopa USP, Levodopa, and Entacapone in different strengths. Healthcare providers are warned against combining lower strength tablets to achieve higher strength tablets due to the risk of Entacapone overdose. The medication is manufactured in Finland by Orion Corporation, distributed by Sun Pharmaceutical industries, and dispensed under prescription only. Batch number and other details are also provided.*
Spl-carton3 (Spl Carton3)
This is a package insert for medication containing a combination of Carbidopa, Levodopa, and Entacapone. It is a treatment for Parkinson's disease. The tablet should be swallowed whole and not crushed, split, or chewed. It should be stored at room temperature and kept in a tight container. The medication should not be given to children and should only be taken as directed by a healthcare provider. The tablets are manufactured in Finland and distributed by Sun Pharmaceutical Industries in the United States. The batch number is not available.*
Spl-carton4 (Spl Carton4)
Carbidopa, Levodopa and Entacapone Tablets are used to treat Parkinson's disease. The tablets are not to be crushed, split or chewed, and should be taken whole. Dosage should be determined by a healthcare provider and adhered to, to avoid entacapone overdose. The tablets are not suitable for use by children and should be stored in a cool dry place between 15-30 degrees Celsius. The medication comes in a tightly sealed container and should not be combined with other tablets to increase the dosage. It is made in Finland and distributed by Sun Pharmaceutical Industries, Inc.*
Spl-carton5 (Spl Carton5)
This is a medication label for a drug called Carbidopa, Levodopa, and Entacapone Tablets. The tablets come in a dosage of 37.5 mg/150 mg/200 mg and should be swallowed whole, not crushed, split, or chewed. They should be stored in a tight container at room temperature, and kept away from children. The tablets contain carbidopa, levodopa, and entacapone and it is manufactured by Orion Corporation in Finland and distributed by Sun Pharmaceutical Industries in the US. Lower strength tablets should not be combined to achieve a higher strength, due to the risk of entacapone overdose. The expiry and batch information is not available.*
Spl-carton6 (Spl Carton6)
This is a prescription drug called "Carbidopa, Levodopa and Entacapone Tablets" used in the treatment of Parkinson's disease. The tablets are manufactured and distributed by Orion Pharma and Sun Pharmaceutical Industries respectively. It is recommended to swallow the tablets as a whole and not to crush, split, or chew them. The tablets should be stored in a tight container at a temperature between 15-30°C. The text also contains dosage recommendations and a warning not to combine lower strength tablets to avoid the risk of Entacapone overdose. The rest of the text contains product and company information that is irrelevant for general use.*
Spl-label1 (Spl Label1)
This is a medication package insert for Carbidopa, Levodopa and Entacapone Tablets used in the treatment of Parkinson's disease. It contains instructions to swallow the tablet whole, not crush, split, or chew. The tablets should be stored at 25°C and dispensed in a tight container. It also warns about the risk of overdose and to keep this and all drugs out of reach of children. The text includes the manufacturer's name, Rion Corporation, and distributor, Sun Pharmaceutical Industries, Inc., and their addresses.*
Spl-label2 (Spl Label2)
This text contains medication instructions for a drug named Carbidopa, Levodopa, and Entacapone. It includes directions on how to take the medication (swallow whole and do not crush or chew), information on storage and dispensing, and a warning not to combine lower strength tablets to achieve a higher strength. The manufacturer and distributer are also mentioned.*
Spl-label3 (Spl Label3)
This is a medication package insert for the drug called "Carbidopa, Levodopa, and Entacapone Tablets". The tablets should be swallowed whole and should not be crushed, split, or chewed. Each tablet contains Carbidopa USP, Levodopa, and a dose of Entacapone. They should be stored at room temperature. The drug should be kept out of reach of children and dispensed in a tight container. It is manufactured by a company in Finland and distributed in New Jersey by a pharmaceutical company. The package insert warns against combining lower strength tablets to achieve higher strength as this can lead to an overdose of Entacapone.*
Spl-label4 (Spl Label4)
This is a description of a medication called Barbidopa, Levodopa and Entacapone Tablets. Each film-coated tablet contains Carbidopa USP 31.25mg, Levodopa USP 125 mg and Entacapone 200 mg. The medicine should not be crushed but swallowed whole and should be kept in a tight container at room temperature. It is important not to combine lower strength tablets to achieve a higher strength tablet due to the risk of Entacapone overdose. The medicine is manufactured by Orion Corporation - Orion Pharma in Finland and distributed by Sun Pharmaceutical Industries, Inc.*
Spl-label5 (Spl Label5)
This is a medication called "Barbldopa Levodopa and Entacapone Tablets" that come in a package of 100 film-coated tablets. Each tablet contains entacapone only. It is not recommended to combine lower strength tablets for a higher strength as it can cause an overdose. It should be swallowed whole and not crushed, split, or chewed. It needs to be stored at a temperature of 25°C (77°F), with excursions between 15-30°C (59-86°F) permitted. The medication should be kept in a tight container away from children. The medication is made in Finland by Orion Pharma and Distributed by Sun Pharmaceutical Industries in Cranbury, NJ.*
Spl-label6 (Spl Label6)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
